National, Prospective, Multicenter,Observational Registry Study on Pulmonary Hypertension Due to Left Heart Disease in China
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 520
- 试验地点
- 1
- 主要终点
- All cause death
研究概览
简要总结
Left heart disease is the main cause of pulmonary hypertension. With the advent of the aging society, chronic heart failure has become a global public health problem. Therefore the prevalence of pulmonary hypertension due to the left heart disease is increasing. However, there is no research on the prevalence of pulmonary hypertension due to the left heart disease in China. Therefore, the aim of the present study was to describe real-world outcome of Chinese patients with pulmonary hypertension due to the left heart disease and identify factors that may predict outcome. Our study will profile the demographics, clinical course, treatments, and outcomes of pulmonary hypertension due to the left heart disease in China.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pulmonary Hypertension due to left heart disease
排除标准
- •Other forms of Pulmonary Hypertension
- •Heart failure due to valvular heart disease
- •Hypertrophic obstructive cardiomyopathy
- •Right ventricular outflow tract stenosis
- •Pericardial disease
- •Patients with chronic lung disease
结局指标
主要结局
All cause death
时间窗: up to 5 years
次要结局
未报告次要终点
研究者
Jianguo He
Director of Pulmonary vascular disease center
Chinese Academy of Medical Sciences, Fuwai Hospital
